P-ISSN 2587-2400 | E-ISSN 2587-196X
Ejmo Kapak
EJMO Volume : 8 Issue : 3 Year : 2024
COVID-19 in EJMO 8/3EJMO Current Issue EJMO Archive EJMO & Congress Most Cited Articles Ahead of Print
Copyright Transfer Form
ICMJE COI Form

Ahead of Print

Abstracts of Oncology and immunotherapy association 2019 Congress
Abstracts of Oncology and immunotherapy association 2019 Congress
doi: 10.14744/ejmo.2019.2019
MiR-19a Mediates Epithelial Mesenchymal Transition of Breast Cancer by Inhibiting KRAS
Xianchou Xu, Peinan Wen, Yinghao Wang, Adheesh Bhandari, Riyuan Zhang, Shuqiang Shi, Ouchen Wang
doi: 10.14744/ejmo.2021.16863
Advancements in Molecular Biomarkers as Prognostic Predictors for Patients with Glioblastoma: A Systematic Review
Renindra Ananda Aman, Yovanka Naryai Manuhutu, Muhamad Aulia Rahman, Nicholas Calvin, Yutha Perdana
doi: 10.14744/ejmo.2024.79543
Follicular Thyroid Adenoma with Signet Ring Cell Morphology; A Rare Case Report
Mehmet Onur Ozturk, Mehmet Celik, Buket Yilmaz Bulbul, Tulin Deniz Yalta, Nuray Can, Semra Ayturk, Sibel Guldiken
doi: 10.14744/ejmo.2017.30602
Abstracts of Oncology and immunotherapy association 2018 Congress
Abstracts Oncology and immunotherapy association
doi: 10.14744/ejmo.2018.2018
ROS1 Rearrangement in Non Small Cell Lung Cancer: Where We are and Where We are going to.
Olga Nigro, Alessandro Tuzi, Graziella Pinotti
doi: 10.14744/ejmo.2020.42771

Submit Manuscript
WEB OF SCIENCE click

  • Impact Factor: 0.8

  • Medicine, General & Internal: Q2 146/322


    • SCOPUS click

  • CiteScoreTracker 2023: 5.6
  • CiteScore year 2022:
    0.9
  • CiteScore year 2021:
    0.2


    • Google Scholar click

  • Number of Articles:315
  • Citations:2587
  • h-index:16
  • i10-index:=26

  • EJMO NLM ID: 101720527

  • Accept Ratio :18.2 %
  • Final decision avg 34 day

    • Copyright © 2024 Eurasian Journal of Medicine and Oncology, EJMO

    EJMO & EJMO